354 related articles for article (PubMed ID: 28571764)
1. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
Isakov N
Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer.
Carter CA
Curr Drug Targets; 2000 Sep; 1(2):163-83. PubMed ID: 11465069
[TBL] [Abstract][Full Text] [Related]
3. Classical PKC isoforms in cancer.
Martiny-Baron G; Fabbro D
Pharmacol Res; 2007 Jun; 55(6):477-86. PubMed ID: 17548205
[TBL] [Abstract][Full Text] [Related]
4. Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside.
Bosco R; Melloni E; Celeghini C; Rimondi E; Vaccarezza M; Zauli G
Mini Rev Med Chem; 2011 Mar; 11(3):185-99. PubMed ID: 21534929
[TBL] [Abstract][Full Text] [Related]
5. Potential role of PKC inhibitors in the treatment of hematological malignancies.
Mischiati C; Melloni E; Corallini F; Milani D; Bergamini C; Vaccarezza M
Curr Pharm Des; 2008; 14(21):2075-84. PubMed ID: 18691117
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C as a tumor suppressor.
Newton AC
Semin Cancer Biol; 2018 Feb; 48():18-26. PubMed ID: 28476658
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents.
Gonelli A; Mischiati C; Guerrini R; Voltan R; Salvadori S; Zauli G
Mini Rev Med Chem; 2009 Apr; 9(4):498-509. PubMed ID: 19356127
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C in cancer: The top five unanswered questions.
Cooke M; Magimaidas A; Casado-Medrano V; Kazanietz MG
Mol Carcinog; 2017 Jun; 56(6):1531-1542. PubMed ID: 28112438
[TBL] [Abstract][Full Text] [Related]
10. Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells.
Kobayashi Y; Bridle KR; Ramm GA; O'neill R; Britton RS; Bacon BR
Liver Int; 2007 Oct; 27(8):1066-75. PubMed ID: 17845534
[TBL] [Abstract][Full Text] [Related]
11. Depletion of protein kinase C-alpha by antisense oligonucleotides alters beta-adrenergic function and reverses the phorbol ester-induced reduction of isoproterenol-induced adenosine 3'-5'-cyclic monophosphate accumulation in murine Swiss 3T3 fibroblasts.
Levesque L; Crooke ST
J Pharmacol Exp Ther; 1998 Oct; 287(1):425-34. PubMed ID: 9765365
[TBL] [Abstract][Full Text] [Related]
12. Definition by specific antisense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes.
Lee YS; Dlugosz AA; McKay R; Dean NM; Yuspa SH
Mol Carcinog; 1997 Jan; 18(1):44-53. PubMed ID: 9022812
[TBL] [Abstract][Full Text] [Related]
13. The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients.
Leskow FC; Krasnapolski MA; Urtreger AJ
Curr Pharm Biotechnol; 2011 Nov; 12(11):1961-73. PubMed ID: 21470133
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.
Fields AP; Regala RP
Pharmacol Res; 2007 Jun; 55(6):487-97. PubMed ID: 17570678
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival.
Dowling CM; Phelan J; Callender JA; Cathcart MC; Mehigan B; McCormick P; Dalton T; Coffey JC; Newton AC; O'Sullivan J; Kiely PA
Oncotarget; 2016 Apr; 7(15):20919-33. PubMed ID: 26989024
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C and other diacylglycerol effectors in cancer.
Griner EM; Kazanietz MG
Nat Rev Cancer; 2007 Apr; 7(4):281-94. PubMed ID: 17384583
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
Chen CC; Wang JK; Lin SB
J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
[TBL] [Abstract][Full Text] [Related]
18. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
[TBL] [Abstract][Full Text] [Related]
19. The PKC universe keeps expanding: From cancer initiation to metastasis.
Rahimova N; Cooke M; Zhang S; Baker MJ; Kazanietz MG
Adv Biol Regul; 2020 Dec; 78():100755. PubMed ID: 33017725
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester-stimulated NF-kappaB-dependent transcription: roles for isoforms of novel protein kinase C.
Holden NS; Squires PE; Kaur M; Bland R; Jones CE; Newton R
Cell Signal; 2008 Jul; 20(7):1338-48. PubMed ID: 18436431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
